معرفی
Adrian Dunlop is Conjoint Professor at the University of Newcastle's School of Medicine and Public Health within the College of Health, Medicine and Wellbeing. He serves as Director and Senior Staff Specialist at Drug & Alcohol Clinical Services, Hunter New England Local Health District (since 2007), and is a key member of the Healthcare Transformation Research Program at Hunter Medical Research Institute. As Chair of NSW Drug & Alcohol Clinical Research & Improvement Network (DACRIN) and President of the Chapter of Addiction Medicine at the Royal Australasian College of Physicians, he leads statewide clinical initiatives.
Education:
- Doctor of Philosophy, University of New South Wales
- Bachelor of Medicine/Bachelor of Surgery, University of Melbourne
- Graduate Diploma in Epidemiology & Biostatistics, University of Melbourne
- Medical Registration, Medical Board of Victoria
Research Focus: Professor Dunlop specializes in addiction medicine with emphasis on opioid, methamphetamine, cannabis, tobacco, and alcohol use disorders. His work integrates clinical service delivery for vulnerable populations including pregnant women, Aboriginal communities, and rural patients. Key innovations include developing depot buprenorphine protocols, telehealth withdrawal services, and trauma-informed therapies like EMDR in addiction settings.
Publication Trends: His recent research (2023-2024) focuses on pharmacotherapy trials for substance use disorders, including long-acting buprenorphine in correctional settings, neuromodulation for methamphetamine dependence, and vaping-assisted tobacco cessation. Studies frequently employ randomized controlled designs and health economic evaluations, with strong emphasis on translational outcomes in real-world clinical practice.
Awards & Honors:
- APSAD Senior Scientist Award (2019)
- Clinician Award for Excellence in Science, Research & Practice (2014)
- James Rankin Orator, APSAD (2015)
- Clinical Leader of the Year, Hunter New England Health District (2010)
- Churchill Fellowship (2005)
- John Dobson Award (1999)
Grants & Leadership: Secured 16 NHMRC grants (10 as Chief Investigator) and 6 NSW Health TRGS grants. Leads the NSW-wide implementation of depot buprenorphine therapy and coordinates multicentre trials like HARMONY (e-cigarettes for smoking cessation in opioid treatment). Directs the Substance Use in Pregnancy and Parenting Service integrating obstetric and addiction care.
Teams & Labs: Heads clinical teams at John Hunter Hospital providing inpatient/ambulatory withdrawal services, consultation-liaison, and community opioid programs. Collaborates internationally through memberships in College of Problems on Drug Dependence (USA), Society for the Study of Addiction (UK), and International Society for Addiction Medicine.
